Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03910660 |
|---|---|
| Brief Title: | A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. |
| First Submitted : | January 4, 2019 |
| First Submitted that Met QC Criteria : | April 8, 2019 |
| First Posted : | April 10, 2019 |
| Last Update Submitted that Met QC Criteria : | May 22, 2023 |
| Last Update Posted : | May 23, 2023 |